Literature DB >> 9854583

Operative management of islet-cell tumors arising in the head of the pancreas.

B J Park1, H R Alexander, S K Libutti, J Huang, D Royalty, M C Skarulis, R T Jensen, P Gorden, J L Doppman, T H Shawker, D L Fraker, J A Norton, D L Bartlett.   

Abstract

BACKGROUND: Pancreatic islet cell tumors (ICTs) can be treated by enucleation or pancreatic resection. We reviewed our experience with ICTs in the head of the pancreas to define indications for enucleation versus pancreaticoduodenectomy.
METHODS: Between January 1982 and December 1997, 48 patients underwent surgical resection for presumed ICTs of the pancreatic head. Of these, 18 were found on pathologic examination to be disease in a lymph node. Thirty patients had 32 true pancreatic head ICTs. We reviewed the operative results and postoperative courses in these patients.
RESULTS: Mean diameter of the ICTs was 15 mm. Twenty-seven patients (90%) underwent successful enucleations. Three patients failed enucleation and underwent pancreaticoduodenectomy. There was no operative mortality. The median time to regular diet was 7 days. The median time to removal of all drains was 22 days. The most common complication was pancreatic fistula (15%). No patient required reoperation for treatment of a fistula.
CONCLUSION: Most ICTs of the pancreatic head can be removed with enucleation, preserving pancreatic tissue and avoiding the morbidity of pancreaticoduodenectomy. The primary indication for pancreaticoduodenectomy is not the size of the lesion but its proximity to the pancreatic duct.

Entities:  

Mesh:

Year:  1998        PMID: 9854583     DOI: 10.1067/msy.1998.92171

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  17 in total

1.  Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.

Authors:  Detlef K Bartsch; Volker Fendrich; Peter Langer; Ilhan Celik; Peter H Kann; Matthias Rothmund
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

2.  Anastomotic leakage in pancreatic surgery.

Authors:  Stefano Crippa; Roberto Salvia; Massimo Falconi; Giovanni Butturini; Luca Landoni; Claudio Bassi
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 3.  Systematic review of minimally invasive pancreatic resection.

Authors:  Christopher D Briggs; Christopher D Mann; Glen R B Irving; Christopher P Neal; Mark Peterson; Iain C Cameron; David P Berry
Journal:  J Gastrointest Surg       Date:  2009-01-07       Impact factor: 3.452

Review 4.  Non-functional pancreatic neuroendocrine tumor as an incidentaloma--a case report and review of literature.

Authors:  Tarun Rustagi; Mridula Rai; Frank Bauer
Journal:  J Gastrointest Cancer       Date:  2013-09

Review 5.  Insulinoma: pathophysiology, localization and management.

Authors:  Joyce J Shin; Phillip Gorden; Steven K Libutti
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

6.  Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.

Authors:  T C Lairmore; V Y Chen; M K DeBenedetti; W E Gillanders; J A Norton; G M Doherty
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

Review 7.  Insulinoma.

Authors:  Aarti Mathur; Philip Gorden; Steven K Libutti
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

8.  An easier method for performing a pancreaticojejunostomy for the soft pancreas using a fast-absorbable suture.

Authors:  Kenichi Hakamada; Shunji Narumi; Yoshikazu Toyoki; Masaki Nara; Kenosuke Ishido; Takuya Miura; Norihito Kubo; Mutsuo Sasaki
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 9.  Predictive factors for pancreatic fistula following pancreatectomy.

Authors:  Matthew T McMillan; Charles M Vollmer
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

10.  Parenchyma-sparing resections for pancreatic neuroendocrine tumors.

Authors:  Rim Cherif; Sébastien Gaujoux; Anne Couvelard; Safi Dokmak; Marie-Pierre Vuillerme; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  J Gastrointest Surg       Date:  2012-08-22       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.